
CAS 1439399-58-2
:CB-839
Description:
CB-839, with the CAS number 1439399-58-2, is a small molecule inhibitor that specifically targets the enzyme glutaminase. This compound is of particular interest in cancer research due to its potential to disrupt the metabolic pathways that cancer cells rely on for growth and proliferation. By inhibiting glutaminase, CB-839 aims to reduce the availability of glutamine, an amino acid that many tumors utilize to support their energy needs and biosynthetic processes. The substance has been studied in various preclinical and clinical settings, particularly in relation to solid tumors and hematological malignancies. CB-839 is typically characterized by its moderate solubility in organic solvents and its stability under physiological conditions. Its mechanism of action highlights the importance of metabolic reprogramming in cancer therapy, making it a promising candidate for combination therapies aimed at enhancing the efficacy of existing treatments. As research continues, the full therapeutic potential and safety profile of CB-839 are being evaluated in clinical trials.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-
CAS:Formula:C26H24F3N7O3SPurity:98%Color and Shape:SolidMolecular weight:571.5741Ref: IN-DA001IMQ
1g512.00€5gTo inquire10gTo inquire1mg44.00€25gTo inquire10mg50.00€25mg65.00€50mg109.00€100mg153.00€250mg219.00€500mg348.00€Telaglenastat
CAS:Telaglenastat (CB 839) (IC50 of 24 nM), an effective, specific, and oral inhibitor, which is bioavailable glutaminase, for recombinant human GAC.Formula:C26H24F3N7O3SPurity:97.57% - 99.89%Color and Shape:SolidMolecular weight:571.57CB 839
CAS:<p>Inhibitor of glutaminase; anti-proliferative</p>Formula:C26H24F3N7O3SPurity:Min. 95%Molecular weight:571.58 g/mol




